pharmaceuticals
36 articles
Investors are showing renewed interest in biotechnology Initial Public Offerings (IPOs) in Hong Kong due to licensing deals and strong post-IPO performance by Chinese drug developers. Industry leaders...
Biotech firm Insilico Medicine has secured a partnership worth up to US$888 million with French pharmaceutical company Servier for the development of new cancer drugs using artificial intelligence tec...
A/S Genmab has acquired 2,978 shares of Merus N.V. on December 26th at an average price of $97.00 per share, resulting in a total purchase value of approximately $288,866. This transaction increased t...
MarketBeat's stock screener highlights five pharmaceutical companies that investors should consider adding to their watchlists: Eli Lilly and Company, Pfizer, Novo Nordisk A/S, Abbott Laboratories, an...
Convenience store chain Lawson plans to launch a service that enables customers to order over-the-counter (OTC) medications for home delivery starting in 2026, contingent upon the easing of OTC drug s...
Coho Partners Ltd. reduced its holdings of Bristol Myers Squibb's stock by 44.3% during the third quarter, selling 38,361 shares and retaining 48,227 shares....
According to MarketBeat's stock screener tool, five healthcare stocks to watch today are UnitedHealth Group, Johnson & Johnson, Intuitive Surgical, Medline, and Medtronic. These companies represent va...
JPMorgan Chase & Co. raised its price target on Xenon Pharmaceuticals shares from $60.00 to $62.00, maintaining an overweight rating for the biopharmaceutical company....
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages
Acumen Pharmaceuticals (NASDAQ:ABOS) has received an average rating of 'Moderate Buy' from the five financial analysts covering the company, as reported by MarketBeat. The analysis includes one sell a...
HC Wainwright has reissued its buy rating for Eupraxia Pharmaceuticals with a target price of $12.00 per share. The report was released on Friday, according to Benzinga....
Tango Therapeutics' share price achieved a new 52-week high during recent trading sessions, peaking at $12.11 and closing at $11.79 with over 7 million shares traded. The stock had previously closed a...
Cantor Fitzgerald Investment Advisors L.P. increased its stake in Pfizer Inc. by 4.8% during the third quarter, adding 25,090 shares to reach a total of 547,184 shares....
MarketBeat's stock screener highlights five medical stocks for investor consideration today: UnitedHealth Group, Eli Lilly and Company, Medline, Novo Nordisk A/S, and Merck & Co., Inc. These companies...
Eli Lilly and Company, Novo Nordisk A/S, and Pfizer are recommended pharmaceutical stocks by MarketBeat's stock screener tool today. These companies are involved in researching, developing, manufactur...
Signal Advisors Wealth LLC reduced its stake in Bristol Myers Squibb Company by 58.9% during the third quarter of this year, according to recent SEC filings. The institution sold off 17,177 shares and...
Squarepoint Ops LLC has purchased 116,502 shares of Organon & Co. (NYSE:OGN) stock in the second quarter, with an estimated value of $1,128,000. This significant purchase indicates a strategic investm...
Fractyl Health, Inc., listed on NASDAQ under symbol GUTS, has received a Moderate Buy rating from five analyst firms. The price target averages at $7.40 over the next 12 months with one sell and four ...
Railway Pension Investments Ltd increased its shareholding in Bristol Myers Squibb Company by acquiring an additional 40,300 shares in the third quarter. The total holdings now stand at 1,139,600 shar...
Shares of Roquefort Therapeutics plc (LON:ROQ) declined by 7.9% on Monday, with the stock trading as low as GBX 1.21 and closing at that price. Approximately 110,784 shares were traded during mid-day,...
Five ratings firms covering HUTCHMED (NASDAQ:HCM) have provided an average recommendation of 'Hold'. The stock rating is split between one sell, three hold, and one buy recommendation according to Mar...
Railway Pension Investments Ltd increased its shareholding in AbbVie Inc. by 33% in the third quarter, adding 211,800 shares to reach a total of 853,949 shares....
Seven financial analysts have given Bradmer Pharmaceuticals Inc., trading on the Toronto Stock Exchange under ticker GLX (TSE:GLX), an average rating of 'Strong Buy'. Among these, one analyst recommen...
According to MarketBeat's stock screener tool, seven key medical stocks to watch include UnitedHealth Group, Eli Lilly and Company, Thermo Fisher Scientific, Johnson & Johnson, Pfizer, Merck & Co., In...
Founders Financial Securities LLC increased its holdings of Vertex Pharmaceuticals Incorporated's stock (NASDAQ: VRTX) by 154.7% in the third quarter, acquiring an additional 1,787 shares, resulting i...
Shares of Syndax Pharmaceuticals (NASDAQ:SNDX) rose to a new one-year high on Tuesday, trading as high as $21.50 and closing at $21.48 with a total volume of 1,371,684 shares. The stock previously clo...
Squarepoint Ops LLC reduced its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK) by 82.3% in the second quarter of this year. The firm now holds 18,398 shares after selling 85,480 shares....
The article mentions upcoming announcements from pharmaceutical company AbbVie but does not provide details....
Osaic Holdings Inc. increased its holdings in Regeneron Pharmaceuticals (NASDAQ: REGN) by purchasing an additional 6,073 shares during the second quarter, resulting in a total of 17,068 shares held as...
Roberto Mignone, director at Teva Pharmaceutical Industries Ltd., sold 77,400 shares on December 16th at an average price of $30.24 per share, amounting to a total transaction value of $2,340,576. Aft...
Eleon Pharmaceuticals shares have been rated with a consensus 'Hold' by five research firms according to Marketbeat. Among these, one firm has given a sell rating, another a hold rating, and three gav...
Generali Asset Management SPA SGR has decreased its holdings in Incyte Corporation (NASDAQ: INCY) by reducing its stock ownership from a previous level down to 24,654 shares after selling 6,280 shares...
During the third quarter, Duncker Streett & Co. Inc. reduced its holdings of Vertex Pharmaceuticals Incorporated by 69.5%, decreasing from 7732 to 2355 shares....
A new joint Russian and Indian pharmaceutical manufacturing facility will be established in the Kaluga region of Russia. Specific details about the plant's capacity, investment amount, or expected pro...
Shares of Roquefort Therapeutics (LON: ROQ) saw an increase of 3.9% on Monday, reaching as high as GBX 1.50 before settling at GBX 1.46. The trading volume was above average with 1,882,007 shares trad...
Generali Asset Management SPA SGR Acquires 6,942 Shares of Vertex Pharmaceuticals Incorporated $VRTX
During the 3rd quarter, Generali Asset Management SPA SGR increased its holdings in Vertex Pharmaceuticals Incorporated by purchasing an additional 6,942 shares, resulting in a total of 23,569 shares....
Supernus Pharmaceuticals has received an average rating of 'Hold' with a consensus price target of $63.25 per share, based on ratings from seven analysts covering the company. The breakdown includes o...